Skip to main content

1-20 of 89 results for primarymember:"Earl Howe"

Session X
2003-04

Type

House

Session

Year

Department

Member

Primary member

Answering member

Legislative stage

Legislation

Subject

More

Publisher


Show detailed: On Off
Results: 10 20 50 100
Sort by: Newest first Oldest first

Supplementary on the risk of varient CJD transmission from plasma products and blood transfusions.
Asked by
Earl Howe (Conservative)
Oral questions - 1st Supplementary
Status
Answered
Date
18 November 2004
Reference
666 c1605
House
House of Lords
Supplementary on adult social care and direct payments.
Asked by
Earl Howe (Conservative)
Oral questions - 1st Supplementary
Status
Answered
Date
2 November 2004
Reference
666 c147
House
House of Lords

What is their policy towards the role of polygraph tests and their evidential value (a) in criminal proceedings; and (b) as part of the process of appeal against criminal conviction [HL 4416].

Asked by
Earl Howe (Conservative)
Type
Written questions
Status
Answered
Date
28 October 2004
Reference
HL 4416; 665 c143WA
House
House of Lords
Supplementary on transmission of CJD by blood transfusions and the banning of recipients of blood transfusions from donating blood.
Asked by
Earl Howe (Conservative)
Oral questions - 1st Supplementary
Status
Answered
Date
28 October 2004
Reference
665 c1397
House
House of Lords
Supplementary on influenza vaccination and the supply of doses available.
Asked by
Earl Howe (Conservative)
Oral questions - 1st Supplementary
Status
Answered
Date
26 October 2004
Reference
665 c1175
House
House of Lords

What are the waiting times and the length of waiting lists for those discovered to be positive for hepatitis C to be seen by a consultant. [HL 4417]. - Not available.

Asked by
Earl Howe (Conservative)
Type
Written questions
Status
Answered
Date
25 October 2004
Reference
HL 4417; 665 c110WA
House
House of Lords
Supplementary on the National Healthy School Standard and the value for money of the programme.
Asked by
Earl Howe (Conservative)
Oral questions - 1st Supplementary
Status
Answered
Date
12 October 2004
Reference
665 c120
House
House of Lords
Supplementary on the effect of salt on health and departmental coordination between the Department of Health and the Food Standards Agency.
Asked by
Earl Howe (Conservative)
Oral questions - 1st Supplementary
Status
Answered
Date
12 October 2004
Reference
665 c117
House
House of Lords
Supplementary on palliative care for non-cancer patients.
Asked by
Earl Howe (Conservative)
Oral questions - 1st Supplementary
Status
Answered
Date
16 September 2004
Reference
664 c1290
House
House of Lords
Supplementary on mental health services for ethnic minorites and funding.
Asked by
Earl Howe (Conservative)
Oral questions - 1st Supplementary
Status
Answered
Date
14 September 2004
Reference
664 c1026
House
House of Lords

What action is being taken to train wide groups of healthcare professionals who come into contact with large areas of patients' skin to check for signs of skin cancer and for lesions. [HL 4012].

Asked by
Earl Howe (Conservative)
Type
Written questions
Status
Answered
Date
13 September 2004
Reference
HL 4012; 664 c174WA
House
House of Lords
Supplementary on the payment of doctors for referring patients to personal injury lawyers and the position with regard to health service employees and the police.
Asked by
Earl Howe (Conservative)
Oral questions - 1st Supplementary
Status
Answered
Date
13 September 2004
Reference
664 c895
House
House of Lords

When they next intend to meet with representatives of Consumers for Health Choice to discuss the regulation of food supplements. [HL 3938].

Asked by
Earl Howe (Conservative)
Type
Written questions
Status
Answered
Date
7 September 2004
Reference
HL 3938; 664 c142WA
House
House of Lords

What guidance they will produce to encourage health professionals to take an opportunistic approach to checking patients' skin for potentially cancerous lesions. [HL 4011].

Asked by
Earl Howe (Conservative)
Type
Written questions
Status
Answered
Date
7 September 2004
Reference
664 c149WA; HL 4011
House
House of Lords

Whether they will consider providing incentives to health professionals to encourage them to check patients' skin for potentially cancerous lesions [HL 4010].

Asked by
Earl Howe (Conservative)
Type
Written questions
Status
Answered
Date
7 September 2004
Reference
664 c148WA; HL 4010
House
House of Lords
Supplementary on NHS treatment of overseas visitors.
Asked by
Earl Howe (Conservative)
Oral questions - 1st Supplementary
Status
Answered
Date
20 July 2004
Reference
664 c90
House
House of Lords

Whether they will publish in the Official Report their response to the European Court of Justice on the case against the Food Supplements Directive and the Food Supplements (England) Regulations 2003 brought by the Health Food Manufacturers Association and the National Association of Health Stores; and whether that response will...

Asked by
Earl Howe (Conservative)
Type
Written questions
Status
Answered
Date
19 July 2004
Reference
HL 3755; 664 c17-8WA
House
House of Lords
Supplementary on the healthy start scheme and access to follow-on formula in the second year of life.
Asked by
Earl Howe (Conservative)
Oral questions - 1st Supplementary
Status
Answered
Date
12 July 2004
Reference
663 c1008-9
House
House of Lords

What is the purpose of the forthcoming European legislation on sports nutrition products; and what steps the Food Standards Agency will be taking to ensure that the interests of the United Kingdom sports nutrition industry are fully protected in the discussions on the forthcoming European sports nutrition legislation; what is...

Asked by
Earl Howe (Conservative)
Type
Written questions
Status
Answered
Date
8 July 2004
Reference
663 c107-8WA; HL 3521
House
House of Lords
Supplementary on the Patient Information and Advisory Group and the effect on patient confidentiality of the national patient record system.
Asked by
Earl Howe (Conservative)
Oral questions - 1st Supplementary
Status
Answered
Date
6 July 2004
Reference
663 c656
House
House of Lords